BusinessEarth Science Tech, Inc. Receives Update from Leading Independent Equity Research & Corporate Firm, SeeThruEquity with a Price Target of $4.12By Nasdaq OMXAug 10, 2017, 12:45 PM UTC
BusinessEarth Science Tech, Inc. Enters into a Joint Venture with Varsity Group, LLC. Under Its Wholly Owned Subsidiary KannaBidioid Inc.By Nasdaq OMXJul 6, 2017, 12:35 PM UTC
BusinessEarth Science Tech, Inc. Receives a Price Target of $4.12 from Leading Independent Equity Research & Corporate Firm, SeeThruEquityBy Nasdaq OMXJun 29, 2017, 12:45 PM UTC
BusinessEarth Science Tech, Inc. Launches Earth Science Pharmaceutical & MSN-2 Medical Device Websites, Adds Michel Gauthier M.D. to the Advisory Board, and Reports Over 80% Profit IncreaseBy Nasdaq OMXJun 19, 2017, 12:15 PM UTC
BusinessETST Launches Cannabis Therapeutics Website, Shares Updates on their CBD-Based Nutraceutical Patents, & Hints on New Products Launching May 2017By Nasdaq OMXApr 20, 2017, 11:55 AM UTC
BusinessEarth Science Tech, Inc. (OTC: ETST) Finalizes Joint Venture with Karmavore Superfoods and Signs New CMO, Sergio CastilloBy Nasdaq OMXJan 25, 2017, 12:45 PM UTC
BusinessEarth Science Tech, Inc. (OTC: ETST) Signs Marketing & Media Agreement with Pearls of Health and Appoints Gabriel Aviles as Chief Sales Officer (CSO).By Nasdaq OMXJan 9, 2017, 12:45 PM UTC
BusinessEarth Science Tech Engages RedChip to Lead Investor Relations EffortsBy Nasdaq OMXDec 28, 2016, 9:05 PM UTC
